We showed that over-expression of CCZ1-MON1A enhanced autophagosome maturation, promoted APP-CTFs, Aβ and P-tau degradation, and alleviated memory defects and neuropathology in AD models. This evidence concerns the gene MAPT and Alzheimer disease.